Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety
pharmaphorum
FEBRUARY 13, 2022
Quris’ BioAI safety prediction platform – which is based on human tissue samples on chips, nanosensors and machine learning – will be compared to traditional in vitro and in vivo laboratory techniques for spotting toxicity.
98 
Let's personalize your content